**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1309-37-1 |Iron (III) Oxide | 100 | 215-168-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
Dust may cause mechanical irritation.
Skin:
Dust may cause mechanical irritation.
Ingestion:
May cause severe and permanent damage to the digestive tract. May
cause liver damage. Causes severe pain, nausea, vomiting, diarrhea,
and shock. May cause hemorrhaging of the digestive tract. The
toxicological properties of this substance have not been fully
investigated.
Inhalation:
Dust is irritating to the respiratory tract. Inhalation of fumes may
cause metal fume fever, which is characterized by flu-like symptoms
with metallic taste, fever, chills, cough, weakness, chest pain,
muscle pain and increased white blood cell count.
Chronic:
Chronic inhalation may cause effects similar to those of acute
inhalation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Immediately flush skin with plenty of water for at least 15 minutes
while removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Non-combustible, substance itself does not burn but may decompose
upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with skin and eyes. Keep
container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 1309-37-1:
United Kingdom, WEL - TWA: 5 mg/m3 TWA (fume, as Fe); 10 mg/m3 TW
(total inhalable, listed as rouge); 4 mg
United Kingdom, WEL - STEL: 10 mg/m3 STEL (fume, as Fe); 30 mg/m3
STEL (total inhalable, listed as rouge); 1
United States OSHA: 10 mg/m3 TWA
Belgium - TWA: 2 ppm VLE (fume, as Fe); 5 mg/m3 VLE (fume, as Fe)
France - VME: 5 mg/m3 VME (as Fe)
Germany: 6 mg/m3 TWA (respirable fraction)
Malaysia: 2 ppm TWA (dust and fume, particulate matter containing
asbestos and <1% crys
Netherlands: 10 mg/m3 MAC (as Fe2O3)
Russia: 4 mg/m3 TWA (dust)
Spain: 5 mg/m3 VLA-ED (dust and fume, as Fe)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: red-brown to black
Odor: none reported
pH: Not available.
Vapor Pressure: 1 mm Hg @ 20C
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 2849 deg F
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Insoluble in water.
Specific Gravity/Density: 5.24 (water=1)
Molecular Formula: Fe2O3
Molecular Weight: 159.6922
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Aluminum, bromine pentafluoride, calcium hypochlorite, carbon
dioxide, cesium carbide, ethylene oxide, hydrazine, performic acid.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1309-37-1: NO7400000 NO7420000 NO7480000
LD50/LC50:
Not available.
Carcinogenicity:
Iron (III) Oxide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 1309-37-1: 0
Canada
CAS# 1309-37-1 is listed on Canada's DSL List.
CAS# 1309-37-1 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1309-37-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/30/1998 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(Piperidylmethyl)-1-Cyclohexanone Hydrochloride, 98%
| 6966-09-2 |
|
Fluorosilicic Acid (25 Wt % Aqueous Solution)
| 7732-18-5 |
|
(S)-(-)-Bupivacaine hydrochloride, 99%
| 27262-48-2 |
|
6,7-Diethoxy-3,4-Dihydroisoquinoline-1(2H)-Thione, 98%
| 0-01-1 |
|
Sodium phosphate, dibasic anhydrous, reagent ACS
| 7558-79-4 |
|
1-Nonanol
| 143-08-8 |
|
2-Acetyl-6,7-Dimethoxy-1-Methylene-1,2,3,4-Tetrahydroisoquinoline,
| 57621-04-2 |
|
Lithium methoxide, 10% solution in methanol
| 865-34-9 |
|
[(3S)-4-Azabicyclo[4.4.0]Dec-3-yl]-N-(Tert-Butyl)Carboxamide, 99%
| 136465-81-1 |
|
C-Benzylcalix(4)resorcinarene
| 0-01-1 |
|
(S)-(-)-2-(2'-Carbomethoxyethyl)-2-Methyl-Cyclohexanone, 98.5+%
| 112898-44-9 |
|
(S)-(-)-alpha-Amino-gamma-butyrolactone hydrochloride, 98%
| 2185-03-7 |
|
N-Benzylmaleimide
| 1631-26-1 |
|
4-(Methylamino)benzoic acid, 97%
| 10541-83-0 |
|
Ethyl (3S)-3-Hydroxybutyrate, 99%
| 56816-01-4 |
|
Hydrofluoric Acid (48-51%), Reagent ACS
| 7664-39-3 |
|
ETHYL (1R,2S)-2-HYDROXYCYCLOHEXANECARBOXYLATE
| 61586-78-5 |
|
Iodic Acid, Reagent ACS (Crystals), 99.5% (Titr.)
| 7782-68-5 |
|
3-Pyrazolidinone Hydrochloride
| 1752-88-1 |
|
Tritylphenol
| 978-86-9 |
|
4-Hydroxy-2-Methoxybenzaldehyde, 98%
| 18278-34-7 |
|
4-Nitrobiphenyl, 98%
| 92-93-3 |
|
6-Iodo-2-picolin-5-ol, 97%
| 23003-30-7 |
|
Ethyl
| 100491-29-0 |
|
D(+)-Carnitine, 98%
| 541-14-0 |
|
D(+)-Carnitinenitrile Chloride, 97%
| 0-01-1 |
|
5-Amino-o-Cresol, 97%
| 2835-95-2 |
|
Hydrogen Peroxide (30% in Water) (Without Stabilizer), Reagent ACS
| 7722-84-1 |
|
4-Amino-o-Cresol, 97%
| 2635-95-2 |
|
Hydroquinone, p.a.
| 123-31-9 |
|
2,3-Difluoro-6-nitrophenol, 97%
| 82419-26-9 |
|
Hydroxylamine Sulfate, 99%
| 10039-54-0 |
|
Hypophosphorous Acid, 50 wt% Solution in Water
| 7732-18-5 |
|
cis-2-Heptene, 97%
| 6443-92-1 |
|
Imidazole
| 288-32-4 |
|
3-Amino-3-Cyclohexylpropionic Acid, 98%
| 129042-71-3 |
|
3-Fluorophenylacetic Acid, 98%(GC)
| 331-25-9 |
|
3-Benzylaminobutyric Acid, 98%
| 14676-01-8 |
|
4-NITROTHIOPHENOL, TECH., 80+%
| 1849-36-1 |
|
ALPHA,ALPHA-DIPHENYLGLYCINE, 98%
| 3060-50-2 |
|
Zirconium(IV) ethoxide, 99%
| 18267-08-8 |
|
Celite high-purity analytical grade
| 61790-53-2 |
|
2-CYANOETHYLHYDRAZINE, 98%
| 353-07-1 |
|
Pentamethylbenzaldehyde, 96%
| 17432-38-1 |
|
4-Chloro-3-nitrobenzenesulfonic acid, sodium salt, 98% (tlc)
| 17691-19-9 |
|
cis-2-Benzylaminomethyl-1-Cyclohexanol Hydrochloride, 98%
| 77612-17-0 |
|
Iron, electrolytically reduced, reagent (powder)
| 7439-89-6 |
|
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
| 0-01-1 |
|
Iron (III) Oxide, 99.999%, -100 Mesh
| 1309-37-1 |
|
Perfluoroadipic acid hydrate, 98%
| 123334-02-1 |
|
|